Total Payments
$1,041
2024 Payments
$177.47
Companies
17
Transactions
74
Medicare Patients
1,067
Medicare Billing
$69,801
Payment Breakdown by Category
Food & Beverage$1,041 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,041 | 74 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $235.72 | 14 | $0 (2023) |
| Novo Nordisk Inc | $175.30 | 29 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $144.23 | 8 | $0 (2022) |
| Okami Medical, Inc. | $119.97 | 1 | $0 (2024) |
| Lilly USA, LLC | $72.70 | 5 | $0 (2020) |
| PFIZER INC. | $44.29 | 3 | $0 (2019) |
| ABBVIE INC. | $41.92 | 2 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $29.80 | 1 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $28.42 | 2 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $26.63 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $177.47 | 3 | Okami Medical, Inc. ($119.97) |
| 2023 | $36.76 | 2 | Dexcom, Inc. ($18.54) |
| 2022 | $205.07 | 31 | Novo Nordisk Inc ($160.97) |
| 2021 | $114.08 | 7 | Boehringer Ingelheim Pharmaceuticals, Inc. ($48.64) |
| 2020 | $127.10 | 8 | GlaxoSmithKline, LLC. ($42.98) |
| 2019 | $76.65 | 3 | GlaxoSmithKline, LLC. ($45.61) |
| 2018 | $111.67 | 8 | GlaxoSmithKline, LLC. ($43.24) |
| 2017 | $191.93 | 12 | GlaxoSmithKline, LLC. ($45.31) |
All Payment Transactions
74 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/04/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $29.80 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/15/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $27.70 | General |
| Category: NEUROSCIENCE | ||||||
| 02/01/2024 | Okami Medical, Inc. | LOBO (Device) | Food and Beverage | Cash or cash equivalent | $119.97 | General |
| Category: Peripheral vascular intervention | ||||||
| 11/10/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Endocrinology | ||||||
| 03/01/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: RESPIRATORY | ||||||
| 12/14/2022 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $12.33 | General |
| Category: Diabetes Care | ||||||
| 12/09/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $3.70 | General |
| Category: Diabetes | ||||||
| 11/22/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $5.54 | General |
| Category: Diabetes | ||||||
| 11/22/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $3.22 | General |
| Category: Diabetes | ||||||
| 11/16/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $3.08 | General |
| Category: Obesity | ||||||
| 11/08/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.95 | General |
| Category: Diabetes | ||||||
| 11/03/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $10.09 | General |
| Category: Diabetes | ||||||
| 10/19/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $9.95 | General |
| Category: Diabetes | ||||||
| 09/29/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $8.04 | General |
| Category: Diabetes | ||||||
| 09/29/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.41 | General |
| Category: Diabetes | ||||||
| 09/20/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $0.56 | General |
| Category: Obesity | ||||||
| 09/16/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: Obesity | ||||||
| 08/23/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $3.04 | General |
| Category: Obesity | ||||||
| 08/19/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: DIABETES | ||||||
| 07/22/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $3.32 | General |
| Category: Diabetes | ||||||
| 07/22/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $2.37 | General |
| Category: Diabetes | ||||||
| 06/28/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.80 | General |
| Category: Diabetes | ||||||
| 06/28/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $4.80 | General |
| Category: Diabetes | ||||||
| 06/24/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.00 | General |
| Category: Diabetes | ||||||
| 06/24/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $3.15 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 292 | 316 | $35,764 | $23,241 |
| 2022 | 9 | 305 | 335 | $39,076 | $16,116 |
| 2021 | 7 | 216 | 234 | $24,224 | $15,485 |
| 2020 | 9 | 254 | 280 | $26,198 | $14,959 |
Total Patients
1,067
Total Services
1,165
Medicare Billing
$69,801
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 68 | 68 | $11,220 | $8,407 | 74.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 78 | 92 | $9,080 | $4,999 | 55.1% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 62 | 62 | $7,440 | $4,464 | 60.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 33 | 42 | $5,970 | $3,558 | 59.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 16 | 16 | $1,280 | $1,151 | 89.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 23 | 23 | $644.00 | $631.12 | 98.0% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 12 | 13 | $130.00 | $31.41 | 24.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 68 | 88 | $8,360 | $3,884 | 46.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 67 | 67 | $11,055 | $3,751 | 33.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 39 | 48 | $6,720 | $2,842 | 42.3% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 11 | 11 | $1,815 | $1,663 | 91.6% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 59 | 59 | $7,080 | $1,510 | 21.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 14 | 14 | $980.00 | $959.56 | 97.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 11 | 11 | $2,300 | $848.73 | 36.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 21 | 22 | $616.00 | $604.24 | 98.1% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 15 | 15 | $150.00 | $53.96 | 36.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 51 | 51 | $8,415 | $6,616 | 78.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 65 | 77 | $7,315 | $3,906 | 53.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 31 | 35 | $4,900 | $2,810 | 57.3% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 22 | 22 | $2,640 | $1,589 | 60.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 18 | 18 | $504.00 | $297.36 | 59.0% |
| 99406 | Smoking and tobacco use intermediate counseling, greater than 3 minutes up to 10 minutes | Office | 2021 | 12 | 14 | $280.00 | $213.22 | 76.1% |
| 96127 | Brief emotional or behavioral assessment | Office | 2021 | 17 | 17 | $170.00 | $55.05 | 32.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 45 | 45 | $7,475 | $5,078 | 67.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 60 | 77 | $7,315 | $3,171 | 43.3% |
About Dr. Derek Gallucci, D.O
Dr. Derek Gallucci, D.O is a Family Medicine healthcare provider based in Williamsville, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/01/2012. The National Provider Identifier (NPI) number assigned to this provider is 1346508991.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Derek Gallucci, D.O has received a total of $1,041 in payments from pharmaceutical and medical device companies, with $177.47 received in 2024. These payments were reported across 74 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,041).
As a Medicare-enrolled provider, Gallucci has provided services to 1,067 Medicare beneficiaries, totaling 1,165 services with total Medicare billing of $69,801. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Williamsville, NY
- Active Since 05/01/2012
- Last Updated 04/26/2016
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1346508991
Products in Payments
- JARDIANCE (Drug) $164.60
- LOBO (Device) $119.97
- TRELEGY ELLIPTA (Drug) $96.19
- Rybelsus (Drug) $69.41
- Ozempic (Drug) $66.25
- ANORO (Drug) $59.63
- ANORO ELLIPTA (Drug) $40.36
- Saxenda (Drug) $39.64
- SHINGRIX (Biological) $39.54
- VOQUEZNA (Drug) $29.80
- CHANTIX (Drug) $29.38
- UBRELVY (Drug) $27.70
- InPen (Device) $25.08
- XIFAXAN (Drug) $22.41
- TRULICITY (Drug) $19.39
- Dexcom G6 Transmitter (Medical Supply) $18.54
- TRADJENTA (Drug) $18.32
- ENTRESTO (Drug) $16.48
- SYMBICORT (Drug) $15.00
- VIAGRA (Drug) $14.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Williamsville
Jean Cange, M.d, M.D
Family Medicine — Payments: $28,012
Family Medicine $28,012
Dr. Daniel Trock, M.d, M.D
Family Medicine — Payments: $22,227
Family Medicine $22,227
Suchitra Koneru, M.d, M.D
Family Medicine — Payments: $15,123
Family Medicine $15,123
Dr. David Pawlowski, Md, MD
Family Medicine — Payments: $14,600
Family Medicine $14,600
Dr. Stacey Gugino, Md, MD
Family Medicine — Payments: $13,585
Family Medicine $13,585
Dr. Karol Pohlman Rejman, Phd, Fnp, PHD, FNP
Family Medicine — Payments: $12,074
Family Medicine $12,074